Vanguard Group’s DNA X Inc SONM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-9,389
| Closed | -$102K | – | 4400 |
|
|
2025
Q3 | $102K | Buy |
+9,389
| New | +$109K | ﹤0.01% | 4225 |
|
|
2025
Q2 | – | Sell |
-2,807
| Closed | -$108K | – | 4324 |
|
|
2025
Q1 | $108K | Hold |
2,807
| – | – | ﹤0.01% | 4131 |
|
|
2024
Q4 | $159K | Hold |
2,807
| – | – | ﹤0.01% | 4126 |
|
|
2024
Q3 | $146K | Buy |
2,807
+1,140
| +68% | +$71.6K | ﹤0.01% | 4169 |
|
|
2024
Q2 | $300K | Buy |
1,667
+1
| +0.1% | +$109 | ﹤0.01% | 4099 |
|
|
2024
Q1 | $183K | Buy |
1,666
+1
| +0.1% | +$123 | ﹤0.01% | 4192 |
|
|
2023
Q4 | $220K | Buy |
1,665
+20
| +1% | +$2.65K | ﹤0.01% | 4206 |
|
|
2023
Q3 | $198K | Hold |
1,645
| – | – | ﹤0.01% | 4253 |
|
|
2023
Q2 | $340K | Buy |
1,645
+1,418
| +625% | +$277K | ﹤0.01% | 4214 |
|
|
2023
Q1 | $41.2K | Hold |
227
| – | – | ﹤0.01% | 4489 |
|
|
2022
Q4 | $17.3K | Buy |
227
+1
| +0.4% | +$82 | ﹤0.01% | 4501 |
|
|
2022
Q3 | $20K | Buy |
+226
| New | +$28.1K | ﹤0.01% | 4590 |
|
|
2022
Q1 | – | Sell |
-1,488
| Closed | -$246K | – | 4639 |
|
|
2021
Q4 | $246K | Buy |
1,488
+113
| +8% | +$34.3K | ﹤0.01% | 4538 |
|
|
2021
Q3 | $668K | Buy |
1,375
+47
| +4% | +$35.7K | ﹤0.01% | 4331 |
|
|
2021
Q2 | $1.33M | Buy |
1,328
+758
| +133% | +$824K | ﹤0.01% | 4090 |
|
|
2021
Q1 | $841K | Buy |
570
+482
| +548% | +$850K | ﹤0.01% | 4045 |
|
|
2020
Q4 | $114K | Hold |
88
| – | – | ﹤0.01% | 4135 |
|
|
2020
Q3 | $122K | Sell |
88
-48
| -35% | -$77.2K | ﹤0.01% | 3999 |
|
|
2020
Q2 | $196K | Sell |
136
-20
| -13% | -$31.9K | ﹤0.01% | 3929 |
|
|
2020
Q1 | $197K | Buy |
156
+8
| +5% | +$38.3K | ﹤0.01% | 3865 |
|
|
2019
Q4 | $968K | Buy |
148
+13
| +10% | +$64.1K | ﹤0.01% | 3650 |
|
|
2019
Q3 | $712K | Buy |
135
+87
| +181% | +$1.34M | ﹤0.01% | 3735 |
|
|
2019
Q2 | $1.09M | Buy |
+48
| New | +$1.22M | ﹤0.01% | 3648 |
|
Other funds holding SONM
PCM
CC
SS
DB
Vanguard Group's SONM Position: Q4 2025 in Review
Vanguard Group sold out of DNA X Inc (SONM) in Q4 2025, closing a stake of 9,389 shares — an estimated $102K sold.
Vanguard Group first reported a position in SONM in Q2 2019 and held it in 23 quarters. The position peaked at $1.33M in Q2 2021. 8 funds tracked by Wall St. Rank hold SONM as of Q4 2025.
- Vanguard Group reported no remaining DNA X Inc position as of Q4 2025 after selling out during the quarter.
- Vanguard Group sold 9,389 DNA X Inc shares in Q4 2025, an estimated $102K.
- Vanguard Group first reported a position in DNA X Inc in Q2 2019 and held it in 23 quarters.
- Vanguard Group's DNA X Inc position peaked at $1.33M in Q2 2021.
- 8 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.